Cargando…
Protective Effects of Pituitary Adenylate-Cyclase-Activating Polypeptide on Retinal Vasculature and Molecular Responses in a Rat Model of Moderate Glaucoma
Despite the high probability of glaucoma-related blindness, its cause is not fully understood and there is no efficient therapeutic strategy for neuroprotection. Vascular factors have been suggested to play an important role in glaucoma development and progression. Previously, we have proven the neu...
Autores principales: | Patko, Evelin, Szabo, Edina, Vaczy, Alexandra, Molitor, Dorottya, Tari, Eniko, Li, Lina, Csutak, Adrienne, Toth, Gabor, Reglodi, Dora, Atlasz, Tamas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10487862/ https://www.ncbi.nlm.nih.gov/pubmed/37686074 http://dx.doi.org/10.3390/ijms241713256 |
Ejemplares similares
-
Retinoprotective Effects of PACAP Eye Drops in Microbead-Induced Glaucoma Model in Rats
por: Szabo, Edina, et al.
Publicado: (2021) -
Retinoprotective Effects of TAT-Bound Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase Activating Polypeptide
por: Atlasz, Tamas, et al.
Publicado: (2018) -
Effects of Pituitary Adenylate Cyclase Activating Polypeptide on Cell Death
por: Horvath, Gabriella, et al.
Publicado: (2022) -
Distribution of PACAP and PAC1 Receptor in the Human Eye
por: Patko, Evelin, et al.
Publicado: (2022) -
Pituitary Adenylate Cyclase-Activating Polypeptide (PACAP) and Sudden Infant Death Syndrome: A Potential Model for Investigation
por: Tóth, Dénes, et al.
Publicado: (2023)